{"id":54385,"date":"2023-03-01T15:07:52","date_gmt":"2023-03-01T14:07:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/"},"modified":"2023-03-01T15:07:52","modified_gmt":"2023-03-01T14:07:52","slug":"nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/","title":{"rendered":"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe"},"content":{"rendered":"
\n

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–#ANDA<\/a>–Nexus Pharmaceuticals, Inc. announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED\u00ae<\/sup><\/b> (ephedrine sulfate injection) in 25mg\/5mL and 50mg\/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cWe are pleased to announce the addition of our latest EMERPHED\u00ae<\/sup><\/b> product to our suite of existing FDA-approved, ready-to-use ephedrine sulfate products,\u201d said Chief Executive Officer and President, Usman Ahmed. \u201cThese patented products showcase Nexus\u2019 ability to provide innovative therapies that address clinicians\u2019 concerns about delivering efficient and safe medications. With EMERPHED\u00ae<\/sup><\/b>, we look forward to transforming how patients are treated, while continuing to offer the quality they\u2019ve come to expect.\u201d\n<\/p>\n

\nNexus received FDA approval for EMERPHED\u00ae<\/sup><\/b> (ephedrine sulfate) Injection in a ready-to-use vial in April 2020. A patent covering certain applications of EMERPHED\u00ae<\/sup><\/b> Ready-to-Use Ephedrine Sulfate Injection was issued by the United States Patent and Trademark Office (USPTO) in August 2021. Nexus has since earned several additional patents on its EMERPHED\u00ae<\/sup><\/b> line of vials and syringes and continues to pursue further parent protection related to EMERPHED\u00ae<\/sup><\/b>.\n<\/p>\n

\nIn February 2021, the Medical College of Wisconsin published a clinical study showing the reduction of potential risk for error and ease of use of EMERPHED\u00ae<\/sup><\/b> (ephedrine sulfate) Injection in a ready-to-use vial as compared to commercially used concentrated ephedrine. MCW published a press release<\/a> with their findings in February 2021, and the clinical study<\/a> was published in the Journal of Pharmaceutical Science and Technology in June 2021.\n<\/p>\n

\n\u201cIn 2020, we were the first manufacturer to launch an FDA-approved ephedrine sulfate injection in a ready-to-use vial. Since that time, the market has changed and refined itself, so we are incredibly excited to introduce the next generation of ready-to-administer ephedrine sulfate products once again,\u201d said Omair Ahmed, Chief Operating Officer.\n<\/p>\n

\nNexus Pharmaceuticals\u2019 EMERPHED\u00ae<\/sup><\/b> (ephedrine sulfate injection) pre-filled syringe is available immediately in cartons of ten single-dose syringes.\n<\/p>\n

\nAbout EMERPHED\u00ae<\/sup> (ephedrine sulfate injection)<\/b>\n<\/p>\n

\nEMERPHED\u00ae<\/sup><\/b> (ephedrine sulfate injection) is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.\n<\/p>\n

\nFor full prescribing information, please see the following link<\/a>.\n<\/p>\n

\nTo report SUSPECTED ADVERSE REACTIONS, contact Nexus Pharmaceuticals at (855) 642-2594 or FDA at 1-800-FDA-1088 or <\/b>www.fda.gov\/medwatch<\/a><\/b><\/span>.<\/b>\n<\/p>\n

\nAbout Nexus Pharmaceuticals, Inc.<\/b>\n<\/p>\n

\nNexus Pharmaceuticals Inc., a US-based healthcare company and certified diverse supplier, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they\u2019re needed most. For more information about Nexus Pharmaceuticals and its state-of-the-art manufacturing facility in Wisconsin, visit https:\/\/www.nexuspharma.net\/project-tomorrow\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDeana Mndrucic
\n
dmndrucic@nexuspharma.net<\/a>
847-996-3790\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–#ANDA–Nexus Pharmaceuticals, Inc. announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED\u00ae (ephedrine sulfate injection) in 25mg\/5mL and 50mg\/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available. \u201cWe are pleased to announce the addition of our latest EMERPHED\u00ae product … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54385","6":"format-standard","7":"category-industry"},"yoast_head":"\nNexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–#ANDA–Nexus Pharmaceuticals, Inc. announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED\u00ae (ephedrine sulfate injection) in 25mg\/5mL and 50mg\/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available. \u201cWe are pleased to announce the addition of our latest EMERPHED\u00ae product ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-01T14:07:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230301005543\/en\/1726865\/21\/EMERPHED.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe\",\"datePublished\":\"2023-03-01T14:07:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/\"},\"wordCount\":485,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005543\\\/en\\\/1726865\\\/21\\\/EMERPHED.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/\",\"name\":\"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005543\\\/en\\\/1726865\\\/21\\\/EMERPHED.jpg\",\"datePublished\":\"2023-03-01T14:07:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005543\\\/en\\\/1726865\\\/21\\\/EMERPHED.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005543\\\/en\\\/1726865\\\/21\\\/EMERPHED.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/","og_locale":"en_US","og_type":"article","og_title":"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe - Pharma Trend","og_description":"LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–#ANDA–Nexus Pharmaceuticals, Inc. announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED\u00ae (ephedrine sulfate injection) in 25mg\/5mL and 50mg\/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available. \u201cWe are pleased to announce the addition of our latest EMERPHED\u00ae product ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-01T14:07:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230301005543\/en\/1726865\/21\/EMERPHED.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe","datePublished":"2023-03-01T14:07:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/"},"wordCount":485,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230301005543\/en\/1726865\/21\/EMERPHED.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/","url":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/","name":"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230301005543\/en\/1726865\/21\/EMERPHED.jpg","datePublished":"2023-03-01T14:07:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230301005543\/en\/1726865\/21\/EMERPHED.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230301005543\/en\/1726865\/21\/EMERPHED.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED\u00ae (ephedrine sulfate injection) Pre-Filled Syringe"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54385"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54385\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}